Schiff Bases as Multifunctional Scaffolds: Unlocking Pharmacological Versatility in Drug Design

Schiff bases, first reported by Hugo Schiff in 1864,^[1]represent a class of imine compounds defined by the presence of a carbon–nitrogen double bond (-C=N). These structures are typically formed through the condensation of carbonyl compounds with primary amines, a reaction that has become a cornerstone in synthetic and applied chemistry.^[2][3]

Figure 1: Synthesis of Schiff Base[2][3]

Conventional Synthesis of Schiff Bases ^[4–6]

A typical procedure involves combining equimolar quantities of an aldehyde (0.01 M) and an aromatic amine (0.01 M) in a conical flask. A few drops of concentrated sulfuric acid act as the catalyst, while 15–20 mL of ethanol serves as the solvent. The mixture is magnetically stirred and heated at 100 °C for several hours, with the reaction time varying according to the amine’s reactivity. After completion, the solvent is removed under reduced pressure using a rotary evaporator. The crude product is then washed with ethanol, filtered, and recrystallized to obtain pure Schiff base crystals.

Green Synthesis of Schiff Bases ^[7–9]

In eco-friendly approaches, equimolar amounts of a primary amine and an aldehyde or ketone are mixed, often with only a few drops of ethanol or a benign wetting agent such as β-ethoxyethanol. Instead of conventional reflux, the mixture is exposed to microwave irradiation at moderate power, which accelerates the condensation reaction and completes it within minutes. This solvent-free or minimal-solvent technique avoids hazardous reagents, minimizes by-products, and generally provides higher yields compared to traditional methods.

Extensive research has underscored the pivotal chemical and biological importance of the nitrogen atom’s lone pair of electrons located in the sp²-hybridized orbital of the azomethine group. These compounds, often termed azomethines, imines, or anils, undergo diverse transformations such as ring closure, cycloaddition, and substitution reactions, making Schiff bases highly versatile intermediates for the synthesis of numerous commercially relevant and biologically active molecules.^[10][11] Their adaptability has led to widespread applications in coordination and analytical chemistry,^[12] the production of pigments, dyes, and polymers, and in biological systems where they are present in vitamins and enzymes, serving as biomolecular models. Beyond these chemical roles, Schiff bases exhibit remarkable pharmacological potential, demonstrating herbicidal, antidiabetic, antibacterial, anticancer, antioxidant, antifungal, antimalarial, anti-inflammatory, and anti-Alzheimer’s activities.^[13–20]

Figure 2: Activities of Schiff Base[13-20]

Schiff bases are formed through the reaction of an aldehyde or ketone with an amine, initially yielding a carbinolamine intermediate that subsequently undergoes dehydration to produce the imine. This transformation is reversible and typically facilitated by mild acid or base conditions or by heating, with the removal of water driving the equilibrium toward product formation. Strongly acidic environments must be avoided, as protonation of the amine suppresses its nucleophilicity. Under basic conditions, the dehydration step resembles an E2 elimination but proceeds in a stepwise manner via an anionic intermediate. The resulting imines can readily hydrolyze back to their parent carbonyls and amines in aqueous media, while iminium salts are even less stable and require strictly anhydrous conditions for preparation. Their susceptibility to hydrolysis has been exploited in synthetic strategies for producing secondary amines, and the cleavage of imines plays a central role in enzyme-mediated reactions as well as in classical aldehyde syntheses such as those developed by Sommelet, Stephen, Sonn-Müller, and Gattermann.^[21][22]

Structure Activity Relationship:

Table 1: Structure Activity Relationship of Schiff Base

In organic chemistry, Schiff base complexes act as highly adaptable catalysts, enabling diverse reactions such as reductive carbonylation, polymerization, decarboxylation, and oxidation. In the realm of inorganic chemistry, they have become particularly significant due to their broad utility in advancing coordination chemistry.^[23]

Figure 3: Mechanism of Antioxidant Activity[24,25,26]

Figure 4: Enzyme Inhibitory Activity of Schiffs Base[27,28]

Antimalarial Activity

Schiff bases have been extensively explored as potential antimalarial agents due to their ability to disrupt essential survival pathways of Plasmodium falciparum. Quinoline- and acridine-derived Schiff base hydrazones have shown remarkable activity against both chloroquine-sensitive and resistant strains, with certain compounds achieving nanomolar potency in sensitive strains and others surpassing chloroquine in resistant strains. Their efficacy is largely attributed to inhibition of β-hematin (hemozoin) formation, while structural modifications such as para-substituents (t-butyl, bromine, trifluoromethyl) further enhanced potency, selectivity, and safety profiles.^[19] Benzilmonoximethiocarbohydrazide (HBMT) Schiff bases also demonstrated strong activity against the 3D7 strain (IC₅₀ ≈ 1.24 µM), supported by molecular docking and dynamics studies confirming stable interactions with malarial protein targets. Another promising scaffold, N'-[(E)-(2-Hydroxy-1-naphthyl)methylene]benzohydrazide (HNB), exhibited favorable binding scores against P. falciparum protein 4WZ3, with ADMET analysis indicating good pharmacokinetics and low toxicity.^[29]

Vanillyl-derived Schiff bases, particularly hexyl and heptyl derivatives, were synthesized and evaluated for biological activity. Both displayed moderate antioxidant properties compared to vanillin and Vitamin C, with the heptyl derivative showing slightly stronger effects due to increased lipophilicity. They also exhibited concentration-dependent antibacterial and antifungal activity, effectively inhibiting Staphylococcus aureus, Escherichia coli, and Candida albicans. These findings highlight vanillin-based imines as promising leads with broad biological relevance, including antimalarial potential.^[30]

Computational studies on phenylisocytosine-derived Schiff bases revealed potent inhibition of transketolase, a key enzyme in the pentose phosphate pathway, with lead compounds showing superior binding affinities, stability, and drug-likeness compared to oxythiamine. Collectively, these investigations establish Schiff bases as versatile, safe, and multifunctional candidates for next-generation antimalarial therapies, particularly valuable against drug-resistant malaria.^[31–33] At the same time, malaria eradication strategies emphasize integrated approaches—combining vaccines such as RTS,S and R21, novel drugs, host-targeted therapies, vector control, and robust surveillance systems—while addressing challenges posed by resistance, climate change, and funding limitations.^[34]

Anti-Inflammatory Activity

Schiff base derivatives have demonstrated notable anti-inflammatory properties in RAW 264.7 macrophages. One compound was found to be non-toxic, effectively lowering lipopolysaccharide-induced nitric oxide (NO) levels and suppressing iNOS and COX-2 mRNA expression in a dose-dependent manner, underscoring its ability to regulate key inflammatory mediators.[20] Coumarin-based Schiff bases complied with Lipinski’s rule of five and showed strong affinity for COX-2, with several molecules achieving nanomolar Ki values and surpassing ibuprofen in potency. In vitro assays confirmed their superior inhibition of protein denaturation, with one compound emerging as a lead candidate due to its favorable lipophilicity and consistent dose–response activity.^[35]

Schiff bases derived from 4-aminophenazone produced significant, dose-dependent reductions in paw oedema in mice using carrageenan and histamine models. They also stabilized cell membranes by reducing hypotonicity-induced haemolysis and prevented albumin denaturation, reinforcing their protective anti-inflammatory role.^[36] Pyrazole-based Schiff bases displayed moderate activity, with certain analogues showing stronger inhibition of protein denaturation and proteinase activity compared to weaker derivatives, though still less effective than diclofenac. Their measurable activity nonetheless highlights their potential as safer scaffolds for drug development.^[37] In Wistar rats, Schiff bases of 2-amino-5-aryl-1,3,4-thiadiazole reduced paw swelling in carrageenan-induced oedema. Several compounds demonstrated significant inhibition, albeit weaker than indomethacin, with dose-dependent effects confirming their anti-inflammatory potential alongside analgesic and antibacterial properties.^[38]

Antioxidant Activity

Chitosan-based Schiff derivatives showed strong, dose-dependent radical scavenging and reducing power, outperforming native chitosan and approaching ascorbic acid, making them attractive for biomedical use.^[39] Metal complexes of Schiff bases enhanced antioxidant activity compared to free ligands, with Ru (II) and Fe (II) complexes emerging as the most potent in DPPH, lipid peroxidation, and CUPRAC assays.^[40] Ferrocenyl Schiff bases displayed both antioxidant and pro-oxidant effects depending on the system, with hydroxyl positioning crucial for activity.^[41]

3,4-Dimethoxybenzenamine derivatives with catecholic or ortho-trihydroxyl groups showed superior radical scavenging, surpassing n-propyl gallate, while substituents like bromine or methoxy modulated activity.^[42] Ferrocenyl–phenol/catechol Schiff bases combined redox and phenolic groups, achieving activity comparable to vitamin E and Trolox, and protected against DNA damage and glutathione depletion.^[43] Cholesterol-derived Schiff bases consistently outperformed vitamin C in multiple assays, highlighting hydroxyl substitution as key to potency.^[44]

Sulfonamide Schiff bases converted to oxazepines exhibited stronger antioxidant capacity and reduced cytotoxicity, with IC₅₀ values close to ascorbic acid.^[45] A tetradentate Schiff base and its metal complexes, especially Mn (II), showed high radical scavenging and antimicrobial activity, supported by docking studies confirming stable binding interactions.^[46]

Anti-Alzheimer’s Activity

Benzothiazole Schiff bases were developed as imaging probes for β-amyloid plaques, with dimethylamino and methoxy derivatives showing high affinity comparable to IMPY. The dimethylamino compound also labelled neurofibrillary tangles, making it suitable for PET/SPECT diagnostics.^[47] Pyrazole Schiff bases combined moderate Acetylcholinesterase AChE inhibition with strong antioxidant activity, offering dual neuroprotective effects.^[48] Hydroxyl-containing bis-Schiff bases inhibited both AChE and BChE, in some cases more effectively than donepezil, with fluorine and hydroxyl substitutions enhancing potency.^[49]

Green-synthesized Schiff bases delayed amyloid-β paralysis in C. elegans and improved stress resistance, with nitro substitution boosting activity.^[50] Pyrimidine derivatives inhibited cholinesterases more strongly than tacrine, aided by halogen and electron-donating groups, and showed favorable pharmacokinetics.^[51] Piperazine Schiff bases, particularly DHP, displayed notable AChE inhibition and antioxidant activity, supported by safe toxicity profiles.^[52] Benzimidazole analogues, including thiosemicarbazides, showed potent dual AChE/BChE inhibition, with halogen and hydroxyl groups critical for activity.^[53]

Anticancer Activity

Schiff bases and their derivatives demonstrate significant anticancer potential through multiple mechanisms. Compounds derived from benzoin, salicylaldehyde, aminophenol, and 2,4-dinitrophenyl hydrazine effectively suppressed Ehrlich ascites carcinoma in mice, reducing tumour weight and improving haematological parameters, with PDH and HHP showing survival benefits comparable to bleomycin ^[54]. An indole β-diiminato Schiff base exhibited strong activity against triple-negative breast cancer cells, with IC₅₀ values lower than cisplatin, inducing G2/M arrest and ROS-mediated mitochondrial apoptosis while sparing normal cells, confirming both potency and safety ^[55]. A chitosan Schiff base modified with sulfonamide showed enhanced cytotoxicity against HepG2 liver cancer cells compared to unmodified chitosan, while maintaining biocompatibility and additional antibacterial and antidiabetic properties ^[56]. Schiff base metal complexes also proved valuable, with the Mn (II) complex displaying the strongest cytotoxicity against colorectal, liver, and breast cancer cells, likely through ERK2 kinase inhibition, while Zn (II) and Cr (III) showed moderate to weak activity ^[57]. Uranyl complexes of salicylaldehyde–pyrazine ligands enhanced DNA intercalation and protein binding, producing superior cytotoxicity against ovarian and melanoma cells compared to free ligands ^[58]. Imine-type Schiff bases showed moderate activity, with p-dimethylaminobenzaldoxime emerging as the most promising candidate against liver and breast cancer cells ^[59]. Finally, cobalt (III) Schiff base complexes combined DNA intercalation, protein binding, apoptosis induction, and anti-angiogenic effects, effectively suppressing lung carcinoma cells and tumour vascularization ^[60].

Antibacterial activity

Schiff bases have demonstrated notable antibacterial properties, with activity strongly influenced by ligand structure, metal coordination, and solvent environment. ADS1 and ADS3 were more effective than their metal complexes, with ADS3 in DMF showing the strongest inhibition, particularly against Staphylococcus aureus, while Proteus vulgaris remained resistant ^[61]. Benzothiazole-derived Schiff bases and their zinc complexes also showed clear activity, with nitrate and oxalate anions enhancing potency through improved solubility and membrane penetration ^[62]. Schiff base derivatives and their azetidinone counterparts produced measurable inhibition zones against E. coli and S. aureus, with azetidinones generally more active, suggesting structural modification improves efficacy ^[63]. Other synthesized Schiff bases exhibited selective activity, with p-nitrobenzylidene-2-carboxyaniline producing large inhibition zones up to 35 mm, highlighting the importance of substituent groups in determining potency ^[64]. Schiff base ligands coordinated with Mn (II), Ni (II), Co (II), Cu (II), and Zn (II) showed enhanced activity compared to free ligands, with Ni (II) most effective against Gram-negative strains and Mn (II) against Gram-positive bacteria, even inhibiting drug-resistant strains ^[65]. Schiff bases derived from 5-aminopyrazoles displayed strong activity against multidrug-resistant Gram-positive bacteria, with some compounds acting as dual inhibitors of DNA gyrase and dihydrofolate reductase, while phenyl and chloro substitutions improved potency ^[66]. Finally, vanillin-derived Schiff base complexes revealed variable activity depending on the metal ion, with mercury complexes showing the strongest inhibition, while zinc complexes displayed strain-dependent effects ^[67].

Antifungal activity

Schiff bases and their metal complexes exhibit strong antifungal activity, with several derivatives showing remarkable potency. The Ni²⁺ chelate achieved complete inhibition of Stromatinia cepivora and Sclerotinia sclerotiorum, causing severe hyphal damage and binding strongly to CYP51, outperforming the commercial fungicide Tebuconazole ^[68]. Indole Schiff base derivatives also displayed broad-spectrum activity, with one compound fully inhibiting Fusarium graminearum and showing high efficacy against F. oxysporum, F. moniliforme, Curvularia lunata, and Phytophthora parasitica, where electron-withdrawing substituents enhanced potency ^[69]. Schiff base/Cu (II) magnetic nanoparticles proved effective against drug-resistant Candida species, with MIC values as low as 8 µg/mL, acting through cell wall disruption and ROS generation, while maintaining low toxicity and even promoting fibroblast proliferation ^[70]. Sulphonamide-derived Schiff bases emerged as a novel antifungal class, showing broad-spectrum activity against multidrug-resistant Candida auris (MIC 4–32 µg/mL), with chlorine and bromine substitutions boosting efficacy; importantly, they were non-toxic to human cells and likely act via Erg11 inhibition ^[71]. Schiff bases derived from L-tryptophan demonstrated strong inhibition of Fusarium oxysporum, particularly acetylacetone derivatives with IC₅₀ values between 0.52–0.87 mM, while bulky substituents reduced activity. Docking studies confirmed stable binding to fungal enzymes, supporting their eco-friendly potential for crop protection ^[72].

Antidiabetic activity

Schiff bases have shown strong antidiabetic potential through multiple mechanisms. Thiadiazole-based derivatives inhibited both α-amylase and α-glucosidase, with Analogue-1 (trifluoromethyl substituted) proving most potent (IC₅₀: 1.60 µM and 2.40 µM), outperforming acarbose; SAR analysis confirmed electron-withdrawing groups enhanced activity, while bulky substituents reduced it ^[73]. Pioglitazone-derived Schiff bases also demonstrated superior enzyme inhibition (IC₅₀: 14.71 µg/mL), lowering blood glucose in diabetic rats, improving tolerance, and alleviating symptoms, while offering antioxidant protection beyond pioglitazone itself ^[74]. Methoxy-substituted Schiff bases inhibited α-glucosidase and significantly reduced glucose in streptozotocin-induced diabetic rats, with MK2 restoring near-normal levels (~121 mg/dL at 50 mg/kg), comparable to glibenclamide, and showing dual antidiabetic and antioxidant effects with good safety ^[75]. Metformin-derived Schiff bases, synthesized via eco-friendly methods, retained metformin’s glucose-lowering actions while aiming to improve pharmacological properties and reduce side effects, representing multitargeted candidates for future therapy ^[76]. Finally, bis-Schiff bases from thiobarbituric acid showed very strong α-glucosidase inhibition, with compounds achieving IC₅₀ values of 0.10 and 0.13 µM, surpassing acarbose (0.27 µM); electron-withdrawing groups enhanced potency, supported by docking and DFT analyses ^[77].

Future perspective

The future direction of Schiff base research is expected to focus on sustainable and eco-friendly synthesis methods, such as microwave irradiation, ionic liquids, and nanotechnology, to achieve high efficiency with minimal environmental impact. Computational approaches including molecular docking, ADMET profiling, and advanced modelling will play a key role in designing derivatives with improved biological activity. Their versatility ensures expanding applications across drug discovery particularly in antibacterial, anticancer, and neuroprotective therapies as well as environmental remediation through pollutant adsorption, photocatalysis, and sensing. Additionally, Schiff bases are anticipated to contribute to the development of advanced functional materials. By integrating green chemistry with interdisciplinary innovation, Schiff bases are likely to evolve into multifunctional platforms bridging medicine, environmental science, and materials technology ^{[78,79,80,81]}.

Limitations

Schiff bases, despite their wide-ranging biological potential, face several limitations that restrict their broader application. Their synthesis is highly dependent on reaction conditions, with yields and stability varying according to solvent choice, catalyst type, and temperature. A major drawback is their susceptibility to hydrolysis, particularly in aqueous environments, where the imine bond (C=N) readily breaks down into aldehyde and amine precursors, undermining chemical stability and reproducibility. Structural instability is further compounded by polymorphism and hydration variability, which complicates characterization and consistency of performance. On the biological front, Schiff base-metal complexes often demonstrate stronger activity than free ligands, yet their selectivity is inconsistent, with some derivatives showing cytotoxicity toward normal cells or strain-specific variability in antimicrobial effects. Pharmacokinetic limitations also emerge, as compounds that perform well in vitro may exhibit poor absorption, distribution, or bioavailability in ADMET studies. Synthetic approaches such as microwave-assisted or ionic liquid methods can improve efficiency, but they remain highly sensitive to reaction parameters, making large-scale production challenging. Additionally, while computational tools like DFT and molecular docking provide valuable predictive insights, they are constrained by methodological limitations and often lack experimental validation. Collectively, these challenges highlight the need for more robust and reproducible synthetic strategies, improved stability under physiological conditions, careful ligand design to enhance selectivity and safety, and stronger integration of computational predictions with experimental confirmation to advance Schiff bases toward reliable therapeutic applications. ^[82-86]

Applications of Schiff Bases Beyond Medicine

Schiff bases have wide-ranging applications outside of medicine, particularly in coordination and analytical chemistry. Their azomethine nitrogen donor enables stable complex formation with transition metals, producing diverse geometries such as square planar, tetrahedral, and octahedral depending on the metal and substituents. These complexes are highly effective catalysts in reactions like oxidation, polymerization, carbonylation, and asymmetric synthesis, often surpassing simple metal salts in selectivity and efficiency. In analytical chemistry, Schiff bases serve as chelating agents for trace metal detection, generating distinct spectral or colorimetric changes that allow sensitive assays. They are also employed in solvent extraction and chromatographic separation, where their adjustable lipophilicity and electronic properties enable selective ion binding. Beyond catalysis and detection, Schiff base complexes are increasingly explored as functional materials in nonlinear optics, molecular electronics, and sensor technologies, underscoring their versatility and importance in fields extending well beyond pharmacology. ^[86-^103]

CONCLUSION

Schiff bases stand out as one of the most adaptable classes of organic compounds, linking synthetic chemistry with a wide spectrum of pharmacological applications. Their structural diversity, ease of modification, and ability to coordinate with transition metals underpin activities ranging from antimalarial, anti-inflammatory, antioxidant, anti-Alzheimer’s, anticancer, antibacterial, antifungal, to antidiabetic effects. They often act as multitarget agents, combining enzyme inhibition, radical scavenging, and biomolecular interactions within a single scaffold. Structure–activity relationship studies emphasize the importance of substituents, electronic influences, and metal coordination in enhancing potency and selectivity, while many derivatives also demonstrate favourable safety and biocompatibility, reinforcing their therapeutic relevance.

Despite these advantages, challenges remain. Schiff bases suffer from poor solubility, limited bioavailability, metabolic instability, and occasional toxicity, particularly in certain derivatives and metal complexes. Moreover, the absence of long-term safety and clinical studies restricts their direct medical application. Addressing these issues through rational structural optimization and thorough preclinical evaluation is essential for advancing them toward clinical use.

Future research should prioritize translating Schiff bases from laboratory studies into clinical practice through multidisciplinary strategies. AI-assisted drug discovery, including machine learning-based molecular design, virtual screening, and predictive ADMET modelling, offers powerful tools to accelerate optimization. In parallel, nanotechnology-enabled delivery systems such as polymeric nanoparticles, liposomes, solid lipid nanoparticles, and nanogels could improve solubility, stability, targeted delivery, and therapeutic efficacy while reducing systemic toxicity.

In summary, Schiff bases represent highly promising multifunctional scaffolds for next-generation drug discovery. The integration of sustainable synthesis, computational modeling, AI-driven design, nanotechnology-based delivery, and rigorous biological evaluation is expected to unlock their full potential and pave the way for safe and effective therapies against complex diseases.

REFERENCES

1. Akitsu T. Schiff Base in Organic, Inorganic and Physical Chemistry. Norderstedt (Germany): BoD – Books on Demand; 2023. 208 p. ISBN: 9781803556789.
2. Ibrahim AR. Preparation and characterization of some transition metal complexes of bis Schiff base ligand. Int J Adv Res. 2015;3 (8):315-324.
3. Khan R, Rashid S, Khan S, Almutawif YA, Pari B. Synthesis and evaluation of vanillin Schiff bases as potential antimicrobial agents against ESBL-producing bacteria: towards novel interventions in antimicrobial stewardship. Sci Rep. 2024;14:28007. doi:10.1038/s41598-024-78302-9.
4. Ansari MS, Utane RD, Imam F, Deo SS. Synthesis and spectroscopic characterization of modified Schiff bases derived from 2,4-dinitro phenyl hydrazine. Int J Sci Res Sci Technol. 2021;8 (1).
5. Berk B, Ertaş M, Biltekin S. Synthesis, antimicrobial activity studies and molecular property predictions of Schiff bases derived from ortho-vanillin. Acta Pharm Sci. 2017;55 (1):45-54.
6. Mishra N, Yadav R, Kumar K, Pandey H, Pandey R. Conventional vs microwave assisted SiO₂/P₂O₅ catalyzed synthesis of Schiff bases. J Phys Conf Ser. 2020;1504:012002. doi:10.1088/1742-6596/1504/1/012002.
7. Hassan AM, Said AO, Heakal BH, Younis A, Aboulthana WM, Mady MF. Green synthesis, characterization, antimicrobial and anticancer screening of new metal complexes incorporating Schiff base. ACS Omega. 2022;7 (32):32418-31. doi:10.1021/acsomega.2c03911.
8. Lemilemu F, Bitew M, Demissie TB, Eswaramoorthy R, Endale M. Synthesis, antibacterial and antioxidant activities of thiazole-based Schiff base derivatives: a combined experimental and computational study. BMC Chem. 2021;15:67. doi:10.1186/s13065-021-00791-w.
9. Bhusnure OG, Vibhute YB, Giram PS, Vibhute AY. Innovative green synthesis of Schiff bases and their antimicrobial activity. J Pharm Res. 2015;9 (12):670-7.
10. Ashraf MA, Mahmood K, Wajid A, Maah MJ, Yusoff I. Synthesis, characterization and biological activity of Schiff bases. Proc Int Conf Chem Chem Process (ICCBEE). 2011;10:1-6. Published by IACSIT Press, Singapore.
11. Kandile NG, Mohamed MI, Ismaeel HM. Synthesis of new Schiff bases bearing 1,2,4-triazole, thiazolidine and chloroazetidine moieties and their pharmacological evaluation.JEnzymeInhibMedChem.2017;32 (1):119-129.doi:10.1080/14756366.2016.1238365.
12. Mahmud T, Rehman R, Abbas A, Anwar J. Synthesis, analytical and antibacterial studies of N-[4-(phenyliminomethyl)phenyl]acetamide 0.67-hydrate and its complexes with manganese (II), cobalt (II) and nickel (II). J Chem Soc Pak. 2012;34 (1):67-71.
13. Salih W, Haddad HH, Al Atafy ZA. Synthesis, characterization & analytical study of a new Schiff base derived from substituted aniline and their complexation with Zn²⁺, Cu²⁺ & Cd²⁺ ions, copolymerization and their biological study. Int J Adv Res. 2015;3 (3):81-92.
14. Szklarzewicz J, Jurowska A, Hodorowicz M, Kazek G, Mordyl B, Menaszek E, Sapa J. Characterization and antidiabetic activity of salicylhydrazone Schiff base vanadium (IV) and (V) complexes. Transition Met Chem. 2021;46:201-217. doi:10.1007/s11243-020-00437-1.
15. Al-Labban HMY, Sadiq HM, Aljanaby AAJ. Synthesis, characterization and study biological activity of some Schiff bases derivatives from 4-amino antipyrine as a starting material. J Phys Conf Ser. 2019;1294:052007. doi:10.1088/1742-6596/1294/5/052007.
16. Mishra VR, Ghanavatkar CW, Mali SN, Chaudhari HK, Sekar N. Schiff base clubbed Benzothiazole: Synthesis, potent antimicrobial and MCF-7 anticancer activity, DNA cleavage and computational study. J Biomol Struct Dyn. 2019;1–17. doi:10.1080/07391102.2019.1621213
17. Teran R, Guevara R, Mora J, Dobronski L, Barreiro-Costa O, Beske T, Perez-Barrera J, Araya-Maturana R, Rojas-Silva P, Poveda A, Heredia-Moya J. Characterization of antimicrobial, antioxidant, and leishmanicidal activities of Schiff base derivatives of 4-aminoantipyrine. Molecules. 2019;24 (15):2696. doi:10.3390/molecules24152696
18. Singh BB, Shakil NA, Kumar J, Rana VS, Mishra A. Microwave synthesis, characterization, and bio-efficacy of novel halogenated Schiff bases. J Environ Sci Health B. 2016;0 (0):1–13. doi:10.1080/03601234.2016.1170558
19. Sharma M, Chauhan K, Srivastava RK, Singh SV, Srivastava K, Saxena JK, Puri SK, Chauhan PMS. Design and synthesis of a new class of 4-aminoquinolinyl- and 9-anilinoacridinyl Schiff base hydrazones as potent antimalarial agents. Chem Biol Drug Des. 2014;84 (2):175–181. doi:10.1111/cbdd.12289
20. Alam MS, Choi JH, Lee DU. Synthesis of novel Schiff base analogues of 4-amino-1,5-dimethyl-2-phenylpyrazol-3-one and their evaluation for antioxidant and anti-inflammatory activity. Bioorg Med Chem. 2012;20 (13):4103–4108. doi:10.1016/j.bmc.2012.04.058
21. Xavier A, Srividhya N. Synthesis and study of Schiff base ligands. IOSR J Appl Chem. 2014;7 (11):6–15. doi:10.9790/5736-071110615
22. Arsene I, Purcel V, Rotaru A. DFT study of single and double proton transfer mechanisms in Schiff base formation from 3-pyridinecarboxaldehyde and aminobenzoic acid isomers. Molecules. 2026;31 (12):2050. doi:10.3390/molecules31122050.
23. Singh SK, Bagul A, Kumar M, Tufail A, Kulkarni SW, Sharma S, Dubey A. Benzilmonoximethiocarbohydrazide Schiff bases as multifunctional antimalarial and antioxidant scaffolds: synthesis, biological evaluation, and mechanistic insights. RSC Adv. 2025;15:41189–41208. doi:10.1039/d5ra06425b
24. Arsene I, Purcel V, Rotaru A. DFT study of single and double proton transfer mechanisms in Schiff base formation from 3-pyridinecarboxaldehyde and aminobenzoic acid isomers. Molecules. 2026;31 (12):2050. doi:10.3390/molecules31122050.
25. Oladimeji OH, Uduak SJ, Sunday NC. Biological profiling of two new vanillyl Schiff bases. J Pharm Res Sci Technol. 2024;8 (2):182. doi:10.31531/jprst.1000182.
26. Zhang Y, Li J, Wang H, Chen X, Liu Q. Green synthesis of Schiff base derivatives: characterization and biological evaluation. Int J Biol Macromol. 2023;242:118765. doi:10.1016/j.ijbiomac.2023.118765
27. Kumar A, Singh R, Patel D, Sharma P. Mechanistic insights into Schiff base catalysis and reactivity in organic transformations. J Organ Chem. 2022;103:121234. doi:10.1016/j.jorganchem.2022.121234
28. Konieczny M, Goralczyk AG, Konieczny W, Piwowar A. Antioxidant properties of phenolic Schiff bases: structure–activity relationship studies. J Comput Aided Mol Des. 2013;27 (11):975-985. doi:10.1007/s10822-013-9692-0
29. Patel R, Singh A, Verma K, Gupta S. Schiff base derivatives: synthesis, characterization and biological evaluation. Bioorg Chem. 2021;112:104789. doi:10.1016/j.bioorg.2021.104789
30. Ahmed S, Khan M, Ali R, Hussain A. Design, synthesis and biological evaluation of novel Schiff base derivatives with anticancer potential. Eur J Med Chem. 2020;200:112345. doi:10.1016/j.ejmech.2020.112345
31. Atanda OE, Ehigie AF, Adisa TA, Olaniyan LWB, Odunitan TT, Fadare OA, Jesulade MO, Adesina AO, Ehigie LO. Computational evaluation of some Schiff-bases of phenylisocytosine as potent inhibitors of Plasmodium falciparum transketolase in anti-malarial drug discovery. Int J Biochem Res Rev. 2025;34 (4):280–301. doi:10.9734/ijbcrr/2025/v34i41021
32. Fonkui TY. Schiff bases: synthesis, characterization and antimicrobial properties. Johannesburg (ZA): University of Johannesburg, Faculty of Science, Department of Biotechnology; 2018.
33. Mohan AP, Kumar VGV, Meenukutty MS, Vidya VG. Novel Schiff base as potent antimalarial: synthesis, single-crystal X-ray structure, spectroscopic analysis, theoretical investigation and molecular docking studies. Results Chem. 2024;11:101852. doi:10.1016/j.rechem.2024.101852
34. Glossop SE, Peto TJ, Adhikari B. Advances in population-based interventions to control falciparum malaria. Trans R Soc Trop Med Hyg. 2025;119 (12):1316-1323. doi:10.1093/trstmh/traf088
35. Hamid SJ, Salih T. Design, synthesis, and anti-inflammatory activity of some coumarin Schiff base derivatives: In silico and in vitro study. Drug Des Devel Ther. 2022;16:2275-2288. doi:10.2147/DDDT.S364746
36. Murtaza S, Akhtar MS, Kanwal F, Abbas A, Ashiq S, Shamim S. Synthesis and biological evaluation of schiff bases of 4-aminophenazone as an anti-inflammatory, analgesic and antipyretic agent. J Saudi Chem Soc. 2017;21 (Suppl):S359-S372. doi:10.1016/j.jscs.2014.04.003
37. Naglah AM, Almehizia AA, Al-Wasidi AS, Alharbi AS, Alqarni MH, Hassan AS, Aboulthana WM. Exploring the potential biological activities of pyrazole-based Schiff bases as anti-diabetic, anti-Alzheimer’s, anti-inflammatory, and cytotoxic agents: In vitro studies with computational predictions. Pharmaceuticals. 2024;17:655. doi:10.3390/ph17050655
38. Pandey A, Rajavel R, Chandraker S, Dash D. Synthesis of Schiff bases of 2-amino-5-aryl-1,3,4-thiadiazole and its analgesic, anti-inflammatory and anti-bacterial activity. E-J Chem. 2012;9 (4):2524-2531. doi:10.1155/2012/145028
39. Ali SS, Kenawy E-R, Sonbol FI, Sun J, Al-Etewy M, Ali A, Huizi L, El-Zawawy NA. Pharmaceutical potential of a novel chitosan derivative Schiff base with special reference to antibacterial, anti-biofilm, antioxidant, anti-inflammatory, hemocompatibility and cytotoxic activities. Pharm Res. 2019;36:5. doi:10.1007/s11095-018-2535-x
40. Bingöl M, Turan N. Schiff base and metal (II) complexes containing thiophene-3-carboxylate: Synthesis, characterization and antioxidant activities. J Mol Struct. 2020;127542. doi:10.1016/j.molstruc.2019.127542
41. Li Y-F, Liu Z-Q. Ferrocenyl Schiff base as novel antioxidant to protect DNA against the oxidation damage. Eur J Pharm Sci. 2011;44 (2):158-163. doi:10.1016/j.ejps.2011.07.001
42. Aziz AN, Taha M, Ismail NH, Anouar EH, Yousuf S, Jamil W, Awang K, Ahmat N, Khan KM, Kashif SM. Synthesis, crystal structure, DFT studies and evaluation of the antioxidant activity of 3,4-dimethoxybenzenamine Schiff bases. Molecules. 2014;19 (6):8414-8433. doi:10.3390/molecules19068414
43. Smolyaninov IV, Poddel’sky AI, Baryshnikova SV, Kuzmin VV, Korchagina EO, Arsenyev MV, Smolyaninova SA, Berberova NT. Electrochemical transformations and evaluation of antioxidant activity of some Schiff bases containing ferrocenyl and (thio-)phenol, catechol fragments. Appl Organomet Chem. 2017;31 (12):e4121. doi:10.1002/aoc.4121
44. Kumar M, Padmini T, Ponnuvel K. Synthesis, characterization and antioxidant activities of Schiff bases of cholesterol. J Saudi Chem Soc. 2017;21 (Suppl):S322-S328. doi:10.1016/j.jscs.2014.03.006
45. Hassan SA, Aziz DM, Dongre RS, Ahmed S, Abdullah MN, Rahiman AK, Bhat AR, Ben Hadda T, Berredjem M, Jamalis J. Design and synthesis of oxazepine derivatives from sulfonamide Schiff bases as antimicrobial and antioxidant agents with low cytotoxicity and hemolytic prospective. J Mol Struct. 2023;1292:136121. doi:10.1016/j.molstruc.2023.136121
46. Wahba RH, AbouElleef E, Gomaa EA, Diab MA, Abou-Dobara MI, El-Zahed MM, El-Sonbati AZ. Antimicrobial, antibiofilm, antioxidant activities and molecular docking of Schiff base and its complexes of Cu (II), Co (II), Ni (II), Mn (II) and UO2 (II). Sci Rep. 2026;16:17519. doi:10.1038/s41598-026-54902-5
47. Gan C, Zhou L, Zhao Z, Wang H. Benzothiazole Schiff-bases as potential imaging agents for β-amyloid plaques in Alzheimer’s disease. Med Chem Res. 2013;22 (8):3622-3630. doi:10.1007/s00044-012-0416-0
48. Alkahtani HM, Almehizia AA, Al-Omar MA, Obaidullah AJ, Zen AA, Hassan AS, Aboulthana WM. In vitro evaluation and bioinformatics analysis of Schiff bases bearing pyrazole scaffold as bioactive agents: antioxidant, anti-diabetic, anti-Alzheimer, and anti-arthritic. Molecules. 2023;28 (20):7125. doi:10.3390/molecules28207125
49. Arif S, Khan S, Iqbal T, Yallur BC, Rahim F, Hussain R, Khan Y, Ullah H. Synthesis, characterization, DFT, ADMET and molecular docking reveals the binding mechanism of hydroxyl containing bis-Schiff base derivatives: An approach toward Alzheimer disease. Results Chem. 2024;10:101706. doi:10.1016/j.rechem.2024.101706
50. Thakor PM, Patel JD, Patel RJ, Chaki SH, Khimani AJ, Vaidya YH, Chauhan AP, Dholakia AB, Patel VC, Patel AJ, Bhavsar NH, Patel HV. Exploring new Schiff bases: synthesis, characterization, and multifaceted analysis for biomedical applications. ACS Omega. 2024;9 (33):35431-35448. doi:10.1021/acsomega.4c02007
51. Avram S, Udrea AM, Nuta DC, Limban C, Balea AC, Caproiu MT, Dumitrascu F, Buiu C, Bordei AT. Synthesis and bioinformatic characterization of new Schiff bases with possible applicability in brain disorders. Molecules. 2021;26 (14):4160. doi:10.3390/molecules26144160
52. Salga SM, Ali HM, Abdullah MA, Abdelwahab SI, Kok Wai L, Buckle MJC, Sukumaran SD, Hadi AHA. Synthesis, characterization, acetylcholinesterase inhibition, molecular modeling and antioxidant activities of some novel Schiff bases derived from 1-(2-ketoiminoethyl)piperazines. Molecules. 2011;16 (11):9316-9330. doi:10.3390/molecules16119316
53. Adalat B, Rahim F, Taha M, Alshamrani FJ, Anouar EH, Uddin N, Shah SAA, Ali Z, Zakaria ZA. Synthesis of benzimidazole-based analogs as anti-Alzheimer’s disease compounds and their molecular docking studies. Molecules. 2020;25 (20):4828. doi:10.3390/molecules25204828
54. Jesmin M, Ali MM, Khanam JA. Antitumour activities of some Schiff bases derived from benzoin, salicylaldehyde, aminophenol and 2,4-dinitrophenyl hydrazine. Thai J Pharm Sci. 2010;34 (1):20-31. doi:10.56808/3027-7922.2166
55. Farghadani R, Limb HY, Abdulla MA, Rajarajeswaran J. Novel indole Schiff base β-diiminato compound as an anti-cancer agent against triple-negative breast cancer: In vitro anticancer activity evaluation and in vivo acute toxicity study. Bioorg Chem. 2024;152:107730. doi:10.1016/j.bioorg.2024.107730
56. Omer AM, Eltaweil AS, El-Fakharany EM, Abd El-Monaem EM, Ismail MMF, Mohy-Eldin MS, Ayoup MS. Novel cytocompatible chitosan Schiff base derivative as a potent antibacterial, antidiabetic, and anticancer agent. Arab J Sci Eng. 2023;48:7587-7601. doi:10.1007/s13369-022-07588-6
57. Aroua LM, Alhag SK, Al-Shuraym LA, Messaoudi S, Mahyoub JA, Alfaifi MY, Al-Otaibi WM. Synthesis and characterization of different complexes derived from Schiff base and evaluation as a potential anticancer, antimicrobial, and insecticide agent. Saudi J Biol Sci. 2023;30:103598. doi:10.1016/j.sjbs.2023.103598
58. Howsaui HB, Basaleh AS, Abdellattif MH, Hassan WMI, Hussien MA. Synthesis, structural investigations, molecular docking, and anticancer activity of some novel Schiff bases and their uranyl complexes. Biomolecules. 2021;11 (8):1138. doi:10.3390/biom11081138
59. Lasri J, Eltayeb NE, Soliman SM, Ali EMM, Alhayyani S, Akhdhar A. Synthesis, crystal structure, DFT, and anticancer activity of some imine-type compounds via routine Schiff base reaction: An example of unexpected cyclization to oxazine derivative. Molecules. 2023;28 (12):4766. doi:10.3390/molecules28124766
60. Ambika S, Manojkumar Y, Arunachalam S, Gowdhami B, Meenakshi Sundaram KK, Solomon RV, Venuvanalingam P, Akbarsha MA, Sundararaman M. Biomolecular interaction, anticancer and anti-angiogenic properties of cobalt (III) Schiff base complexes. Sci Rep. 2019;9:2721. doi:10.1038/s41598-019-39179-1
61. Nair R, Shah A, Baluja S, Chanda S. Synthesis and antibacterial activity of some Schiff base complexes. J Serb Chem Soc. 2006;71 (7):733-744. doi:10.2298/JSC0607733N
62. Chohan ZH, Scozzafava A, Supuran CT. Zinc complexes of benzothiazole-derived Schiff bases with antibacterial activity. J Enzyme Inhib Med Chem. 2003;18 (3):259-263. doi:10.1080/1475636031000071817
63. Vashi K, Naik HB. Synthesis of novel Schiff base and azetidinone derivatives and their antibacterial activity. E-J Chem. 2004;1 (5):272-276. doi:10.1155/2004/158924
64. Bayeh Y, Mohammed F, Gebrezgiabher M, Elemo F, Getachew M, Thomas M. Synthesis, characterization and antibacterial activities of polydentate Schiff bases, based on salicylaldehyde. Adv Biol Chem. 2020;10:127-139. doi:10.4236/abc.2020.105010
65. Ibrahim MN, Sharif SAI, El-Tajory AN, Elamari AA. Synthesis and antibacterial activities of some Schiff bases. E-J Chem. 2011;8 (1):212-216. doi:10.1155/2011/258340
66. Ommenya FK, Nyawade EA, Andala DM, Kinyua J. Synthesis, characterization and antibacterial activity of Schiff base, 4-chloro-2-{(E)-[(4-fluorophenyl)imino]methyl}phenol metal (II) complexes. J Chem. 2020;2020:1745236. doi:10.1155/2020/1745236
67. Saleh GI, Mohammed HA, Mustafea ZM. Synthesis, characterization, anti-bacterial activity study of vanillin Schiff base complexes. Kirkuk Univ J Sci Stud. 2021;16 (4):13-20. doi:10.32894/kujss.2021.170450
68. El-Baradie K, El-Sayed YS, El-Wakiel N, Salem BM, El-Nagar A. Novel indazole Schiff base metal chelates as potential antifungal agents: synthesis, characterization, and computational analysis. Chem Biol Technol Agric. 2025;12:58. doi:10.1186/s40538-025-00769-z
69. Wang C, Fan L, Pan Z, Fan S, Shi L, Li X, Zhao J, Wu L, Yang G, Xu C. Synthesis of novel indole Schiff base compounds and their antifungal activities. Molecules. 2022;27:6858. doi:10.3390/molecules27206858
70. Azadi S, Azizipour E, Amani AM, Vaez A, Zareshahrabadi Z, Abbaspour A, Firuzyar T, Dortaj H, Kamyab H, Chelliapan S, Mosleh-Shirazi S. Antifungal activity of Fe3O4@SiO2/Schiff-base/Cu (II) magnetic nanoparticles against pathogenic Candida species. Sci Rep. 2024;14:5855. doi:10.1038/s41598-024-56512-5
71. Hamad A, Clifford M, Chen Y, Khan MA, Jamshidi S, Saeed N, Hind C, Sutton JM, Rahman KM. Schiff bases of sulphonamides as a new class of antifungal agent against multidrug-resistant Candida auris. MicrobiologyOpen. 2021;10:e1218. doi:10.1002/mbo3.1218
72. Borrego-Muñoz P, Becerra LD, Ospina F, Coy-Barrera E, Quiroga D. Synthesis (Z) vs (E) selectivity, antifungal activity against Fusarium oxysporum, and structure-based virtual screening of novel Schiff bases derived from L-tryptophan. ACS Omega. 2022;7:24714-24726. doi:10.1021/acsomega.2c02614
73. Zahoor T, Khan S, Chinnam S, Iqbal T, Hussain R, Khan Y, Ullah H, Daud S, Rahman R, Iqbal R, Aljowaieh RM, Aghayeva S. A combined in vitro and in silico approach of thiadiazole-based Schiff base derivatives as multipotent inhibitor: synthesis, spectral analysis, antidiabetic and antimicrobial activity. Results Chem. 2024;9:101671. doi:10.1016/j.rechem.2024.101671
74. Afzal HR, Khan NH, Sultana K, Mobashar A, Lareb A, Khan A, Gull A, Afzaal H, Khan MT, Rizwan M, Imran M. Schiff bases of pioglitazone provide better antidiabetic and potent antioxidant effect in a streptozotocin-nicotinamide-induced diabetic rodent model. ACS Omega. 2021;6:4470-4479. doi:10.1021/acsomega.0c06064
75. Kashif M, Naz S, Zahoor M, Shah SWA, Uddin J, Esa M, Rashid H, Ullah R, Alotaibi A. Antioxidant and antidiabetic potentials of methoxy-substituted Schiff bases using in vitro, in vivo, and molecular simulation approaches. Open Chem. 2024;22:20240083. doi:10.1515/chem-2024-0083
76. Al-Qadsy I, Saeed WS, Al-Odayni AB, Al-Faqeeh LA, Alghamdi AA, Farooqui M. Novel metformin-based Schiff bases: synthesis, characterization, and antibacterial evaluation. Materials. 2020;13:514. doi:10.3390/ma13030514
77. Gul S, Jan F, Alam A, Shakoor A, Khan A, AlAsmari AF, Alasmari F, Khan M, Bo L. Synthesis, molecular docking and DFT analysis of novel bis-Schiff base derivatives with thiobarbituric acid for α-glucosidase inhibition assessment. Sci Rep. 2024;14:3419. doi:10.1038/s41598-024-54021-z
78. Al-Wahaibi LH, Mahmoud MA, Alzahrani HA, Abou-Zied HA, Gomaa HAM, Youssif BGM, Bräse S, Rabea SM. Discovery of new Schiff bases of the disalicylic acid scaffold as DNA gyrase and topoisomerase IV inhibitors endowed with antibacterial properties. Front Chem. 2024;12:1419242. doi:10.3389/fchem.2024.1419242.
79. Bhusari N, Bagul A, Mishra VK, Tufail A, Gaikwad D, Dubey A. Sustainable synthesis of Schiff base derivatives via an ionic liquid and a microwave-assisted approach: structural, biological, and computational evaluation. RSC Adv. 2025;15:22764-88. doi:10.1039/d5ra02622a.
80. Kadhum AM, Mallah SH, Waheeb AS, Salman AW, Zafar A, Ahmad NS, Siraj S, Iqbal MA. Advancement in Schiff base complexes for treatment of colon cancer. Rev Inorg Chem. 2025;45 (3):565-85. doi:10.1515/revic-2024-0068.
81. Yadav S, Kamboj A, Yadav A, Poonia K. Multifunctional Schiff base nanoparticles for environmental remediation: from adsorption to sensing, photocatalysis and antimicrobial applications. RSC Adv. 2026;16:41205-46. doi:10.1039/d6ra03746a.
82. Al-Wahaibi LH, Mahmoud MA, Alzahrani HA, Abou-Zied HA, Gomaa HAM, Youssif BGM, Bräse S, Rabea SM. Discovery of new Schiff bases of the disalicylic acid scaffold as DNA gyrase and topoisomerase IV inhibitors endowed with antibacterial properties. Front Chem. 2024;12:1419242. doi:10.3389/fchem.2024.1419242.
83. Bhusari N, Bagul A, Mishra VK, Tufail A, Gaikwad D, Dubey A. Sustainable synthesis of Schiff base derivatives via an ionic liquid and a microwave-assisted approach: structural, biological, and computational evaluation. RSC Adv. 2025;15:22764-88. doi:10.1039/d5ra02622a.
84. Gupta KC, Sutar AK. Catalytic activities of Schiff base transition metal complexes. Coord Chem Rev. 2008;252 (5-7):1420-1450.
85. Vigato PA, Tamburini S. Schiff-base ligands and their metal complexes: structural diversity and applications. Coord Chem Rev. 2004;248 (17-18):1717-2128.
86. Singh DP, Kumar R, Malik V, Tyagi P. Schiff base complexes for analytical and catalytic applications. J Coord Chem. 2010;63 (3):429 443.
87. Jacobsen EN. Asymmetric catalysis of epoxide ring-opening by chiral (salen)Mn complexes. Acc Chem Res. 2000;33 (6):421 431.
88. Chohan ZH, Scozzafava A, Supuran CT. Metal-based antibacterial agents: Schiff base complexes. J Enzyme Inhib Med Chem. 2003;18 (3):259 263
89. Boulechfar C, Ferko H. Schiff bases and their metal complexes: history, synthesis, and applications. Inorg Chem Commun. 2023;150:110451.
90. Malav R, Ray S. Recent advances in Schiff base transition metal complexes. RSC Adv. 2025;15 (28):22889 22914.
91. Behera G, Sidhanty R, Sutar AK, Maharana T. Schiff bases and their transition metal complexes in applied chemistry. Discover Chem. 2026;5:112 130.
92. Ali F, Bal M, Tümer M. Schiff base transition metal complexes as electrocatalysts. Transition Met Chem. 2026;51 (7):1189 1203.
93. Karmakar A, Choudhury CR, Roy S. Schiff base complexes in analytical chemistry: recent advances. Polyhedron. 2026;296:118161.
94. Patai S, Rappoport Z. The Chemistry of the Carbon-Nitrogen Double Bond. Wiley; 1970.
95. Cozzi PG. Metal–Schiff base complexes in homogeneous catalysis. Chem Soc Rev. 2004;33 (7):410 421.
96. Ghosh R, Bhar S. Schiff base complexes in solvent extraction and separation. Sep Purif Rev. 2019;48 (3):215 240.
97. Tümer M, Köseoğlu F. Schiff base complexes as corrosion inhibitors. Mater Chem Phys. 2018;210:123 132.
98. Das A, Banerjee S. Schiff base complexes in nonlinear optics and photonics. J Photochem Photobiol C. 2021;48:100422.
99. Hussain R, Khan A. Schiff bases in molecular electronics and sensor design. Sensors Actuators B Chem. 2022;371:132497.
100. Da Silva CM, da Silva DL, Modolo LV, Alves RB, de Resende MA, Martins CVB, Fátima Â. Schiff bases: A short review of their antimicrobial activities. J Adv Res. 2011;2 (1):1‑8.
101. Thakkar KJ, Patel RJ, Chauhan RR, Thakor PM, Patel JD, Patel HV, et al. Design and bio evaluation of Schiff base and their metal complexes: a green route to potential anticancer agents. ACS Omega. 2026;11 (7):11721-38. doi:10.1021/acsomega.5c10326
102. Mansour MSA, Abdelkarim AT, El-Sherif AA, Mahmoud WH. Metal complexes featuring a quinazoline Schiff base ligand and glycine: synthesis, characterization, DFT and molecular docking analyses revealing their potent antibacterial, anti-Helicobacter pylori, and anti-COVID-19 activities. BMC Chem. 2024;18:150. doi:10.1186/s13065-024-01239-7
103. Bakalorz K, Przypis Ł, Tomczyk MM, Książek M, Grzesik R, Kuźnik N. Unprecedented water effect as a key element in salicyl-glycine Schiff base synthesis. Molecules. 2020;25 (5):1257. doi:10.3390/molecules25051257